PIM1 and plasma cell myeloma: Pre‐clinical studies on multiple myeloma (MM) and chronic lymphocytic leukemia (CLL) revealed cytotoxic effects, especially under microenvironmental conditions leading to enhanced Pim expression [29, 30, 31].